Difficulties on the access to innovative targeted therapies for lung cancer in Spain.
Virginia CalvoCarlos CampsEnric CarcerenyManuel CoboManuel DómineMaría Rosario García CampeloJosé Luis González LarribaMaría GuiradoFlorentino Hernando-TranchoBartomeu MassutíErnest NadalDelvys Rodríguez-AbreuAlfredo SánchezIvana Gabriela SullivanMariano Provencionull nullPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
SLCG considers imperative to improve the access in Spain to innovative treatments for NSCLC to reduce inequity across European countries.